Tong Ren Tang Technologies Co. Ltd. logo

Tong Ren Tang Technologies Co. Ltd.

1666.HK

HKSEHealthcareDrug Manufacturers - General

Latest quote

HK$3.19

−HK$0.10 · -3.04%

Aug 24, 11:49 AM HKT

1666.HK company overview

Regular session · HKT · Market data may be delayed.

Company profile

Company website

Tong Ren Tang Technologies Co. Ltd., a company founded in 1669 and based in Beijing, People's Republic of China, maintains extensive operations across Mainland China and Hong Kong. Its primary activities center on the manufacturing and sale of traditional Chinese medicine products. The company's involvement is comprehensive, extending to the cultivation, sourcing, and distribution of Chinese medicinal raw materials. Beyond its core offerings, Tong Ren Tang diversifies its product portfolio with items such as ointments, tea beverages, and specialized foot care solutions. The enterprise is also active in the technological advancement and commercialization of biological products, alongside Western pharmaceuticals, cosmetics, and general healthcare goods. Its distribution network includes both wholesale and retail channels for Chinese medicines and health-related products. Furthermore, Tong Ren Tang provides a broad spectrum of services, including medical research and development, Chinese medical consultation and treatment, advertising, internal and external surgical procedures, medical examinations, and hospital management. Additionally, the company engages in the processing of biochemical products, plant extraction, and the production of various food and daily chemical items.

Industry
Drug Manufacturers - General
Sector
Healthcare
Headquarters
CN
CEO
Chun You Zhang
Listed since
Oct 31, 2000
Employees
3,951

Market position

Day range

Current HK$3.19

52-week range

Current HK$3.19

Open
HK$3.29
Previous close
HK$3.29
Volume
1.06M
0.88× average
Average volume
1.2M
Average daily volume
Market cap
4.09B HKD
Beta
0.79
Market reference 1
50-day average
HK$3.3813
-5.66% below average
200-day average
HK$4.0073
-20.40% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
2.54B CNY
P/E (TTM)
8.97×
P/B (TTM)
0.48×
P/S (TTM)
0.54×
EV / EBITDA
2.53×
Earnings yield
7.81%
Free cash flow yield
28.49%
Dividend yield
6.49%

Profitability & efficiency

Gross margin
38.03%
Operating margin
12.37%
Net margin
6.11%
Return on equity
5.40%
Return on assets
2.89%
Return on invested capital
5.20%

Financial health

Debt / equity
0.3×
Current ratio
5.72×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends47%32%17%2%Gross margin, FY2021: 42.43%Gross margin, FY2022: 43.26%Gross margin, FY2023: 42.04%Gross margin, FY2024: 39.64%Gross margin, FY2025: 38.03%Operating margin, FY2021: 19.99%Operating margin, FY2022: 20.25%Operating margin, FY2023: 16.48%Operating margin, FY2024: 13.57%Operating margin, FY2025: 12.37%Net margin, FY2021: 9.39%Net margin, FY2022: 9.73%Net margin, FY2023: 8.71%Net margin, FY2024: 7.19%Net margin, FY2025: 6.11%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 42.43%. Gross margin FY2022 43.26%. Gross margin FY2023 42.04%. Gross margin FY2024 39.64%. Gross margin FY2025 38.03%. Operating margin FY2021 19.99%. Operating margin FY2022 20.25%. Operating margin FY2023 16.48%. Operating margin FY2024 13.57%. Operating margin FY2025 12.37%. Net margin FY2021 9.39%. Net margin FY2022 9.73%. Net margin FY2023 8.71%. Net margin FY2024 7.19%. Net margin FY2025 6.11%.

Income trends

Revenue

6.48B CNY-10.69%

Operating income

802.14M CNY-18.58%

Net income

396.28M CNY-24.06%
Income trends across reported periods7.95B CNY5.2B CNY2.46B CNY−290.06M CNYRevenue, FY2021: 5.4B CNYRevenue, FY2022: 5.99B CNYRevenue, FY2023: 6.77B CNYRevenue, FY2024: 7.26B CNYRevenue, FY2025: 6.48B CNYOperating income, FY2021: 1.08B CNYOperating income, FY2022: 1.21B CNYOperating income, FY2023: 1.12B CNYOperating income, FY2024: 985.16M CNYOperating income, FY2025: 802.14M CNYNet income, FY2021: 507.25M CNYNet income, FY2022: 582.89M CNYNet income, FY2023: 590.19M CNYNet income, FY2024: 521.8M CNYNet income, FY2025: 396.28M CNYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 5.4B CNY. Revenue FY2022 5.99B CNY. Revenue FY2023 6.77B CNY. Revenue FY2024 7.26B CNY. Revenue FY2025 6.48B CNY. Operating income FY2021 1.08B CNY. Operating income FY2022 1.21B CNY. Operating income FY2023 1.12B CNY. Operating income FY2024 985.16M CNY. Operating income FY2025 802.14M CNY. Net income FY2021 507.25M CNY. Net income FY2022 582.89M CNY. Net income FY2023 590.19M CNY. Net income FY2024 521.8M CNY. Net income FY2025 396.28M CNY.
Metric (CNY)FY2025FY2024FY2023FY2022FY2021
Revenue6.48B CNY7.26B CNY6.77B CNY5.99B CNY5.4B CNY
Cost of goods sold4.02B CNY4.38B CNY3.93B CNY3.4B CNY3.11B CNY
Gross profit2.47B CNY2.88B CNY2.85B CNY2.59B CNY2.29B CNY
Research and development82.76M CNY84.82M CNY117.56M CNY78.43M CNY48.9M CNY
Selling, general, and administrative1.6B CNY1.89B CNY1.71B CNY1.39B CNY1.21B CNY
Operating expenses1.66B CNY1.89B CNY1.73B CNY1.38B CNY1.21B CNY
Interest income68.94M CNY76.23M CNY91.13M CNY44.22M CNY28.05M CNY
Interest expense59.07M CNY64.46M CNY45.05M CNY53.8M CNY61.8M CNY
Depreciation and amortization199.07M CNY186.11M CNY186.11M CNY179.21M CNY175.88M CNY
Operating income802.14M CNY985.16M CNY1.12B CNY1.21B CNY1.08B CNY
Net income396.28M CNY521.8M CNY590.19M CNY582.89M CNY507.25M CNY

Company facts updated Aug 24, 2026.

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

HK$0.1966

2025 complete year+1.1% since 2021

2026 partial: HK$0.2069

* Partial calendar year in the available dividend history.

Corporate action history

Dividend

Ex-dividend Jun 16, 2026

HK$0.2069

Annual

Record Jun 17, 2026 · Payment Aug 11, 2026

Dividend

Ex-dividend Jun 16, 2025

HK$0.1966

Annual

Record Jun 17, 2025 · Payment Aug 11, 2025

Dividend

Ex-dividend Jun 14, 2024

HK$0.1978

Annual

Record Jun 17, 2024 · Payment Aug 9, 2024

Dividend

Ex-dividend Jun 19, 2023

HK$0.1758

Annual

Record Jun 20, 2023 · Payment Aug 14, 2023

Dividend

Ex-dividend Jun 20, 2022

HK$0.1869

Annual

Record Jun 21, 2022 · Payment Aug 15, 2022

Dividend

Ex-dividend Jun 10, 2021

HK$0.1945

Annual

Record Jun 11, 2021 · Payment Aug 5, 2021

1666.HK peers

Continue in GoAI

Research 1666.HK

research.disclaimer